s6y

4 G1 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001562180-24-005658

Documents

  1. PRIMARY DOCUMENT 4
  2. POA EX-24

On sec.gov